Cannabis-derived compound could form part of the obesity medication puzzle

By combining compounds from cannabis and vitamin A, a team of Australian researchers has uncovered a promising new approach to fat-busting medication. The team's work may pave the way for obesity treatments with fewer side effects than current medications and negate the need for invasive surgeries.

An active compound of cannabis is known to regulate appetite and influence fat formation in humans, but researchers have baulked at the effect it can have on the brain. Researchers at Deakin University have now found a way to nullify these adverse effects.

This involves combining it with retinoic acid, which is an active component of vitamin A. The researchers say how this interacts with the endocannabinoid system to provide the fat-reducing effect isn't exactly clear, but testing the drug in zebrafish and human cells nonetheless returned promising results.

"The complementary actions of the endocannabinoid system and retinoic acid pathway in reducing fat deposits...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.gizmag.com/anti-obesity-pill-cannabis/38906/